Sandoz to Stop Notifying CEs of 340B Contract Pharmacy Changes, Joins Liquidia in Adding Restrictions to New Drugs; Novartis Updates Restrictions

Sandoz announced in a June 4 notice to covered entities it “will no longer be providing additional notification for product changes to [its] contract pharmacy policy.”
Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Premier Asks Court to Reject HRSA’s Defense of 340B Hospital Drug Purchasing Restrictions Policy, Requests Oral Arguments

Premier again asked a Washington D.C. federal court to strike down a HRSA policy that restricts how certain 340B hospitals can purchase initial drug inventory.
A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Drugmakers File Briefs in 5th Circuit Appeals Case, Updates in Utah and Nebraska

Key briefs were filed in litigation on contract pharmacy access laws in Louisiana, Utah and Nebraska.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Stakeholders Offer Mixed Views on Trump’s Plan to Move Drug Pricing Program to CMS

340B advocates and stakeholders offered mixed reactions to President Donald Trump's HHS budget request, which called for moving the 340B program to CMS.
340B stakeholders and attorneys offered mixed initial reactions this week to President Donald Trump’s proposal to move the 340B program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Katie Miller, Key Player in Anti-340B ‘Dark Money’ Campaign, Leaves White House Adviser Role

Katie Miller, a key figure in a dark money anti-340B campaign, has left her role as a White House adviser.
A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Cassidy Says 340B ‘Was Never Meant to be Part of an Earnings Call’

U.S. Sen. Bill Cassidy (R-La.) discussed the 340B program in a recent interview with Punchbowl News.
A key U.S. senator on 340B policy continued to raise concerns this week about the current state of the drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BI Asks Tennessee Contract Pharmacies to Report Claims Data Ahead of New State Law, BMS Updates Contract Pharmacy Restrictions

Boehringer Ingelheim announced new 340B claims data requirements for Tennessee covered entities.
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Defends 340B Hospital Drug Purchasing Restrictions Policy, Asks Federal Court to Reject Premier’s Challenge

HHS attorneys recently urged a Washington D.C. federal court to uphold a 2013 HRSA policy and reject Premier's claim that it unlawfully restricts how certain 340B hospitals can purchase initial drug inventory.
The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Vermont House Modifies 340B Contract Pharmacy Access and Hospital Reporting Bill, Hospital Advocates Voice Concerns About Changes

Vermont House lawmakers voted Friday to approve an amended contract pharmacy access bill, which includes price caps on some hospitals that has raised concerns from some state health systems.
The Vermont House on Friday approved a 340B contract pharmacy access bill with Senate-backed hospital reporting requirements and a new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Drugmaker Lobbying Group Adds Hospital, Drugmaker: Key Thune Staffer Departs for Private Sector

The 340B Working Table has added Boston Medical Center Health System and Takeda Pharmaceuticals America to its list of members.
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added another major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live